Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DORNY D MATTHEW | General Counsel | Apr 01 | Option Exercise | 30.63 | 6,200 | 189,906 | 55,359 | Apr 02 06:03 PM | DORNY D MATTHEW | General Counsel | Apr 01 | Sale | 53.16 | 6,200 | 329,592 | 49,159 | Apr 02 06:03 PM | NAPIERSKI RYAN S | President | Mar 15 | Option Exercise | 30.63 | 10,000 | 306,300 | 91,861 | Mar 16 05:13 PM | NAPIERSKI RYAN S | President | Mar 15 | Sale | 52.48 | 10,000 | 524,839 | 81,861 | Mar 16 05:13 PM | CHANG JOSEPH Y | Chief Scientific Officer | Mar 09 | Sale | 51.55 | 626 | 32,270 | 17,942 | Mar 10 05:10 PM | DORNY D MATTHEW | General Counsel | Mar 01 | Option Exercise | 30.63 | 12,400 | 379,812 | 61,890 | Mar 01 05:28 PM | DORNY D MATTHEW | General Counsel | Mar 01 | Sale | 52.09 | 12,400 | 645,936 | 49,490 | Mar 01 05:28 PM | CAMPBELL DANIEL W | Director | Feb 18 | Buy | 49.48 | 5,055 | 250,121 | 10,010 | Feb 22 04:47 PM | CAMPBELL DANIEL W | Director | Feb 18 | Buy | 49.49 | 5,055 | 250,172 | 85,812 | Feb 22 04:47 PM | CHANG JOSEPH Y | Chief Scientific Officer | Feb 18 | Sale | 49.77 | 1,125 | 55,991 | 19,067 | Feb 18 06:31 PM | CAMPBELL DANIEL W | Director | Feb 17 | Buy | 50.69 | 4,955 | 251,169 | 4,955 | Feb 18 06:29 PM | CAMPBELL DANIEL W | Director | Feb 17 | Buy | 50.60 | 4,955 | 250,723 | 80,757 | Feb 18 06:29 PM | LUND STEVEN | Exec. Chairman of the Board | Feb 17 | Buy | 48.05 | 20,850 | 1,001,842 | 240,692 | Feb 18 06:10 PM | NAPIERSKI RYAN S | President | Feb 16 | Option Exercise | 30.63 | 7,000 | 214,410 | 90,015 | Feb 16 05:48 PM | NAPIERSKI RYAN S | President | Feb 16 | Sale | 49.06 | 7,000 | 343,445 | 83,015 | Feb 16 05:48 PM | NAPIERSKI RYAN S | President | Jan 20 | Option Exercise | 30.63 | 8,400 | 257,292 | 83,656 | Jan 20 06:09 PM | NAPIERSKI RYAN S | President | Jan 20 | Sale | 59.12 | 10,156 | 600,423 | 73,500 | Jan 20 06:09 PM | NAPIERSKI RYAN S | President | Jan 15 | Option Exercise | 30.63 | 7,000 | 214,410 | 82,256 | Jan 19 06:24 PM | NAPIERSKI RYAN S | President | Jan 15 | Sale | 55.45 | 7,000 | 388,150 | 75,256 | Jan 19 06:24 PM | NAPIERSKI RYAN S | President | Jan 07 | Option Exercise | 30.63 | 1,600 | 49,008 | 80,100 | Jan 08 05:21 PM | NAPIERSKI RYAN S | President | Jan 07 | Sale | 59.05 | 4,844 | 286,038 | 75,256 | Jan 08 05:21 PM | DORNY D MATTHEW | General Counsel | Jan 04 | Option Exercise | 30.63 | 6,200 | 189,906 | 50,573 | Jan 04 07:19 PM | DORNY D MATTHEW | General Counsel | Jan 04 | Sale | 55.02 | 6,200 | 341,133 | 44,373 | Jan 04 07:19 PM | NAPIERSKI RYAN S | President | Dec 15 | Option Exercise | 30.63 | 7,000 | 214,410 | 85,500 | Dec 15 05:09 PM | NAPIERSKI RYAN S | President | Dec 15 | Sale | 50.97 | 7,000 | 356,790 | 78,500 | Dec 15 05:09 PM | DORNY D MATTHEW | General Counsel | Dec 01 | Option Exercise | 30.63 | 6,200 | 189,906 | 50,573 | Dec 02 04:55 PM | DORNY D MATTHEW | General Counsel | Dec 01 | Sale | 50.81 | 6,200 | 314,996 | 44,373 | Dec 02 04:55 PM | Lawrence Mark H | Chief Financial Officer | Dec 01 | Sale | 50.61 | 3,993 | 202,086 | 48,526 | Dec 02 04:52 PM | WOODBURY EDWINA D | Director | Nov 17 | Sale | 53.16 | 2,500 | 132,900 | 10,956 | Jan 26 06:55 PM | NAPIERSKI RYAN S | President | Nov 16 | Option Exercise | 30.63 | 7,000 | 214,410 | 88,500 | Nov 17 05:00 PM | NAPIERSKI RYAN S | President | Nov 16 | Sale | 51.99 | 7,000 | 363,930 | 81,500 | Nov 17 05:00 PM | DORNY D MATTHEW | General Counsel | Nov 11 | Option Exercise | 30.63 | 6,200 | 189,906 | 51,873 | Nov 12 04:06 PM | DORNY D MATTHEW | General Counsel | Nov 11 | Sale | 51.14 | 6,200 | 317,063 | 45,673 | Nov 12 04:06 PM | NAPIERSKI RYAN S | President | Oct 15 | Option Exercise | 30.63 | 7,000 | 214,410 | 88,500 | Oct 19 04:41 PM | NAPIERSKI RYAN S | President | Oct 15 | Sale | 54.53 | 7,000 | 381,708 | 81,500 | Oct 19 04:41 PM | NAPIERSKI RYAN S | President | Oct 02 | Option Exercise | 30.63 | 10,000 | 306,300 | 91,500 | Oct 05 04:35 PM | NAPIERSKI RYAN S | President | Oct 02 | Sale | 54.47 | 10,000 | 544,650 | 81,500 | Oct 05 04:35 PM | NAPIERSKI RYAN S | President | Sep 24 | Option Exercise | 30.63 | 17,000 | 520,710 | 103,500 | Sep 25 06:29 PM | NAPIERSKI RYAN S | President | Sep 24 | Sale | 51.18 | 22,000 | 1,125,960 | 81,500 | Sep 25 06:29 PM | DORNY D MATTHEW | General Counsel | Sep 23 | Option Exercise | 30.63 | 6,200 | 189,906 | 51,873 | Sep 25 06:57 PM | DORNY D MATTHEW | General Counsel | Sep 23 | Sale | 51.71 | 6,200 | 320,599 | 45,673 | Sep 25 06:57 PM | CHANG JOSEPH Y | Chief Scientific Officer | Sep 10 | Option Exercise | 39.51 | 1,761 | 69,577 | 21,683 | Sep 10 07:15 PM | CHANG JOSEPH Y | Chief Scientific Officer | Sep 10 | Sale | 50.87 | 6,869 | 349,423 | 14,814 | Sep 10 07:15 PM | CHANG JOSEPH Y | Chief Scientific Officer | Sep 09 | Option Exercise | 39.51 | 5,039 | 199,091 | 29,853 | Sep 10 07:15 PM | CHANG JOSEPH Y | Chief Scientific Officer | Sep 09 | Sale | 49.92 | 9,931 | 495,756 | 19,922 | Sep 10 07:15 PM | NAPIERSKI RYAN S | President | Aug 17 | Sale | 47.24 | 5,000 | 236,200 | 86,500 | Aug 18 04:05 PM | CHANG JOSEPH Y | Chief Scientific Officer | Jun 05 | Sale | 40.01 | 34,970 | 1,399,150 | 37,882 | Jun 08 07:12 PM |
|